These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA. Dwivedi R; Tiroumal S Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791 [TBL] [Abstract][Full Text] [Related]
4. Topical dorzolamide treatment of macular cysts in the enhanced S-cone syndrome patient. Kiszkielis M; Lubiński W; Penkala K Doc Ophthalmol; 2013 Jun; 126(3):241-6. PubMed ID: 23292616 [TBL] [Abstract][Full Text] [Related]
5. Resolution of Unilateral Dome-Shaped Macula With Serous Detachment After Treatment of Topical Carbonic Anhydrase Inhibitors. Chen NN; Chen CL; Lai CH Ophthalmic Surg Lasers Imaging Retina; 2019 Aug; 50(8):e218-e221. PubMed ID: 31415708 [TBL] [Abstract][Full Text] [Related]
6. Considering photodynamic therapy as a therapeutic modality in selected cases of dome-shaped macula complicated by foveal serous retinal detachment. Arapi I; Neri P; Mariotti C; Gesuita R; Pirani V; Freddo F; Lutaj P; Giovannini A Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):217-23. PubMed ID: 25707047 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of topical dorzolamide for treatment of cystic macular lesions in a patient with enhanced S-cone syndrome. Genead MA; Fishman GA; McAnany JJ Doc Ophthalmol; 2010 Dec; 121(3):231-40. PubMed ID: 20842519 [TBL] [Abstract][Full Text] [Related]
8. Resolution of mid-peripheral schisis in x-linked retinoschisis with the use of dorzolamide. Collison FT; Genead MA; Fishman GA; Stone EM Ophthalmic Genet; 2014 Jun; 35(2):125-7. PubMed ID: 23514609 [No Abstract] [Full Text] [Related]
9. Use of dorzolamide for patients with X-linked retinoschisis. Apushkin MA; Fishman GA Retina; 2006 Sep; 26(7):741-5. PubMed ID: 16963845 [TBL] [Abstract][Full Text] [Related]
10. Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child. Bušić M; Bjeloš M; Bosnar D; Ramić S; Bušić I Doc Ophthalmol; 2016 Feb; 132(1):67-73. PubMed ID: 26803827 [TBL] [Abstract][Full Text] [Related]
12. The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa. Ikeda Y; Hisatomi T; Yoshida N; Notomi S; Murakami Y; Enaida H; Ishibashi T Graefes Arch Clin Exp Ophthalmol; 2012 Jun; 250(6):809-14. PubMed ID: 22215259 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome. Genead MA; Fishman GA Arch Ophthalmol; 2010 Sep; 128(9):1146-50. PubMed ID: 20837798 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis. Genead MA; Fishman GA; Walia S Arch Ophthalmol; 2010 Feb; 128(2):190-7. PubMed ID: 20142541 [TBL] [Abstract][Full Text] [Related]
15. Effect of topical dorzolamide therapy on cystoid macular edema in hydroxychloroquine retinopathy. Kim DG; Yoon CK; Kim HW; Lee SJ Can J Ophthalmol; 2018 Jun; 53(3):e103-e107. PubMed ID: 29784170 [No Abstract] [Full Text] [Related]
16. Effect of Topical Dorzolamide on Cystoid Macular Edema in Retinitis Pigmentosa. Shimokawa S; Fujiwara K; Murakami Y; Funatsu J; Nakatake S; Yoshida N; Sonoda KH; Ikeda Y Ophthalmol Retina; 2020 Oct; 4(10):1036-1039. PubMed ID: 32454228 [No Abstract] [Full Text] [Related]
17. Natural history and effect of therapeutic interventions on subretinal fluid causing foveal detachment in macular telangiectasia type 2. Mehta H; Müller S; Egan CA; Degli Esposti S; Tufail A; Sim DA; Holz FG; Browning AC; Amoaku WM; Charbel Issa P; Gillies MC Br J Ophthalmol; 2017 Jul; 101(7):955-959. PubMed ID: 27793821 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Carbonic Anhydrase Inhibitors on Cystoid Fluid Collections and Visual Acuity in Patients with X-Linked Retinoschisis. Hensman J; Hahn LC; van Schooneveld MJ; Diederen RMH; Ten Brink JB; Florijn RJ; Bergen AA; Strubbe I; Heutinck P; van Genderen MM; van den Born LI; Thiadens AA; de Zaeytijd J; Leroy BP; Hoyng CB; Boon CJF Ophthalmol Retina; 2024 Jun; 8(6):600-606. PubMed ID: 38104928 [TBL] [Abstract][Full Text] [Related]